Detailed Information
Cited 8 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Analysis of clinical and genomic subgroups from the JAVELIN Bladder 100 trial.
- Authors
- Powles, T[Powles, Thomas]; Petrylak, DP[Petrylak, Daniel P.]; Park, SH[Park, Se Hoon]; Sridhar, SS[Sridhar, Srikala S.]; Caserta, C[Caserta, Claudia]; Vuillemin, AT[Vuillemin, Antoine Thiery]; Lee, HJ[Lee, Hyo Jin]; Bellmunt, J[Bellmunt, Joaquim]; Yamamoto, Y[Yamamoto, Yoshiaki]; Aragon-Ching, JB[Aragon-Ching, Jeanny B.]; Huang, B[Huang, Bo]; Ching, KA[Ching, Keith A.]; Davis, CB[Davis, Craig B.]; Di Pietro, A[Di Pietro, Alessandra]; Loriot, Y[Loriot, Yohann]; Grivas, P[Grivas, Petros]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.